Antiplatelet drugs: which targets for which treatments?
Author:
- 1 June 2015
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 13 (S1) , S313-S322
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- New Approaches to Inhibiting Platelets and CoagulationAnnual Review of Pharmacology and Toxicology, 2015
- Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?American Heart Journal, 2014
- Novel antiplatelet agents in acute coronary syndromeNature Reviews Cardiology, 2014
- Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb‐IX‐V, and CLEC‐2Journal of Thrombosis and Haemostasis, 2013
- Historical perspective and future directions in platelet researchJournal of Thrombosis and Haemostasis, 2011
- AspirinCirculation, 2011
- The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bendBlood, 2008
- Activation of Platelet Function Through G Protein–Coupled ReceptorsCirculation Research, 2006
- REGULATION OF PLATELET FUNCTIONS BY P2 RECEPTORSAnnual Review of Pharmacology and Toxicology, 2006
- Clopidogrel and Ticlopidine: P2Y12Adenosine Diphosphate-Receptor Antagonists for the Prevention of AtherothrombosisSeminars in Thrombosis and Hemostasis, 2005